Key facts
- It has raised $5.0M; the latest was Early Stage VC in Feb 2026.
- Notable investors include SND Ventures Group, Dalton Venture, Marathon Venture Partners, Wuhan Jiangxia Technology Investment Group, Hubei Xiachuang Venture Capital Management — 9 tracked in total.
- Status: Privately Held (backing).
Investors
9- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for ICE Intelligent Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for ICE Intelligent Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ICE Intelligent Healthcare
Manufacturer of intracardiac echo devices intended for structural heart disease and electrophysiology. The company offers cardiovascular interventional imaging and provides ICE imaging of heart and blood vessel diseases, as well as during procedures, thereby enabling doctors to improve the effectiveness and safety of surgery during the entire process of cardiovascular disease diagnosis and treatment.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Employees
- 50
- Website
- ice-intel.com/
- Ownership
- Privately Held (backing)
ICE Intelligent Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ICE Intelligent Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ICE Intelligent Healthcare in its N-PORT filings yet. We sweep new filings monthly.